ArticlePharmacoEconomics - open2026

Cost Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Older Adults in Portugal.

Eleftherios Zarkadoulas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.